Neos Therapeutics Announces The Appointment Of Richard I. Eisenstadt As Chief Financial Officer
5/22/2014 7:42:31 AM
Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today the appointment of Richard I. Eisenstadt to the role of Chief Financial Officer, effective immediately.
Help employers find you! Check out all the jobs and post your resume.
comments powered by